Antitumor necrosis factor, infliximab, and adalimumab: use with caution in eosinophilic bowel disease.
Furuta GT, Atkins D, Capocelli KE, de Zoeten EF, Fleischer D, Menard-Katcher C. Antitumor necrosis factor, infliximab, and adalimumab: use with caution in eosinophilic bowel disease. J Pediatr Gastroenterol Nutr. 2013 Oct; 57(4):e25.